导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.61% | 3726/4773 |
| 近一周 | -2.12% | 1265/5462 |
| 近一月 | -1.33% | 916/5421 |
| 近一季 | -4.30% | 1592/5209 |
| 近半年 | -7.54% | 3228/4920 |
| 近一年 | -6.96% | 3205/4366 |
| 近两年 | 30.77% | 2238/2954 |
| 近三年 | 24.59% | 1295/2253 |
| 成立以来 | 52.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.45% 4287/4961 |
1.93% 2977/5312 |
- - |
- - |
| 2025 | 15.22% 2563/4813 |
4.99% 850/3635 |
-4.87% 3515/4076 |
14.47% 2903/4524 |
0.78% 1773/4813 |
| 2024 | 24.10% 307/3463 |
6.36% 295/2808 |
-0.79% 838/3014 |
16.23% 1503/3129 |
1.19% 1106/3463 |
| 2023 | 5.02% 204/2656 |
9.35% 410/2280 |
5.13% 70/2385 |
-4.38% 1128/2515 |
-4.46% 1039/2655 |
| 2022 | -19.15% 808/2207 |
-20.21% 1530/1919 |
15.59% 168/2016 |
-10.92% 466/2113 |
-1.59% 1714/2208 |
| 2021 | -8.63% 1054/1822 |
-0.59% 375/1255 |
2.46% 1004/1330 |
-15.74% 1390/1466 |
6.47% 217/1822 |
| 2020 | - - |
- - |
- - |
9.01% 683/1164 |
15.79% 191/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 国泰中证全指家用电器ETF联接A VS. 长安沪深300非周期A(740101) |